| JNJ - JOHNSON & JOHNSON | 94,193,000,000 | 2025 | 28.46% | | 6.05% | 11.03 |
| PG - PROCTER & GAMBLE Co | 84,284,000,000 | 2025 | 18.95% | 24.26% | 0.29% | 6.51 |
| LLY - ELI LILLY & Co | 65,179,000,000 | 2025 | 31.67% | | 44.70% | 22.95 |
| MRK - Merck & Co., Inc. | 65,011,000,000 | 2025 | 28.08% | | 1.31% | 7.28 |
| PFE - PFIZER INC | 62,579,000,000 | 2025 | 12.42% | | -1.65% | 1.36 |
| ABBV - AbbVie Inc. | 61,160,000,000 | 2025 | 6.91% | 24.65% | 8.57% | 2.36 |
| BMY - BRISTOL MYERS SQUIBB CO | 48,194,000,000 | 2025 | 14.64% | | -0.22% | 3.46 |
| ABT - ABBOTT LABORATORIES | 44,328,000,000 | 2025 | 14.72% | 18.17% | 5.67% | 3.72 |
| DOW - DOW INC. | 39,968,000,000 | 2025 | -6.11% | | -6.97% | -3.70 |
| AMGN - AMGEN INC | 36,751,000,000 | 2025 | 20.98% | 24.71% | 9.95% | 14.23 |
| LIN - LINDE PLC | 33,986,000,000 | 2025 | 20.30% | 26.25% | 2.97% | 14.61 |
| LYB - LyondellBasell Industries N.V. | 30,153,000,000 | 2025 | -2.45% | -1.39% | -9.71% | -2.34 |
| GILD - GILEAD SCIENCES, INC. | 29,443,000,000 | 2025 | 28.90% | 34.04% | 2.40% | 6.78 |
| CL - COLGATE PALMOLIVE CO | 20,382,000,000 | 2025 | 10.46% | 16.22% | 1.40% | 2.63 |
| ECL - ECOLAB INC. | 16,081,200,000 | 2025 | 12.91% | 17.02% | 2.16% | 7.28 |
| PPG - PPG INDUSTRIES INC | 15,875,000,000 | 2025 | 9.93% | | 0.19% | 6.94 |
| KVUE - Kenvue Inc. | 15,124,000,000 | 2025 | 9.72% | 15.96% | -2.14% | 0.76 |
| REGN - REGENERON PHARMACEUTICALS, INC. | 14,342,900,000 | 2025 | 31.41% | 24.95% | 0.99% | 41.48 |
| EL - ESTEE LAUDER COMPANIES INC | 14,326,000,000 | 2025 | -7.91% | -5.48% | -8.21% | -3.15 |
| VTRS - Viatris Inc | 14,299,900,000 | 2025 | -24.58% | -18.62% | -2.98% | -3.00 |
| MOS - MOSAIC CO | 12,052,400,000 | 2025 | 4.49% | 6.82% | 8.36% | 1.70 |
| APD - Air Products & Chemicals, Inc. | 12,037,300,000 | 2025 | -3.28% | -7.29% | -0.52% | -1.77 |
| VRTX - VERTEX PHARMACEUTICALS INC / MA | 12,001,300,000 | 2025 | 32.94% | 34.77% | 8.90% | 15.32 |
| WLK - WESTLAKE CORP | 11,170,000,000 | 2025 | -13.50% | -14.13% | -8.01% | -11.70 |
| IFF - INTERNATIONAL FLAVORS & FRAGRANCES INC | 10,890,000,000 | 2025 | -3.30% | -3.51% | -5.17% | -1.41 |
| BIIB - BIOGEN INC. | 9,890,600,000 | 2025 | 13.07% | | 2.22% | 8.79 |
| CE - Celanese Corp | 9,544,000,000 | 2025 | -12.21% | -8.24% | -7.05% | -10.64 |
| ZTS - Zoetis Inc. | 9,467,000,000 | 2025 | 28.23% | | 2.28% | 6.02 |
| EMN - EASTMAN CHEMICAL CO | 8,752,000,000 | 2025 | 5.42% | | -6.71% | 4.10 |
| RPM - RPM INTERNATIONAL INC/DE/ | 7,372,644,000 | 2025 | 9.34% | | 0.51% | 5.35 |
| CLX - CLOROX CO /DE/ | 7,104,000,000 | 2025 | 11.40% | | 0.16% | 6.52 |
| CF - CF Industries Holdings, Inc. | 7,084,000,000 | 2025 | 25.38% | 32.47% | 19.34% | 8.97 |
| DD - DuPont de Nemours, Inc. | 6,849,000,000 | 2025 | -11.37% | | 1.93% | -1.86 |
| OLN - OLIN Corp | 6,780,800,000 | 2025 | -1.49% | 0.08% | 3.68% | -0.88 |
| OGN - Organon & Co. | 6,216,000,000 | 2025 | 3.01% | | -2.92% | 0.72 |
| CHD - CHURCH & DWIGHT CO INC /DE/ | 6,203,200,000 | 2025 | 11.88% | 17.37% | 1.57% | 3.02 |
| COTY - COTY INC. | 5,892,900,000 | 2025 | -6.24% | 4.09% | -3.68% | -0.44 |
| CC - Chemours Co | 5,808,000,000 | 2025 | -6.65% | | 0.45% | -2.57 |
| HUN - Huntsman CORP | 5,683,000,000 | 2025 | -5.00% | -2.31% | -5.85% | -1.65 |
| ALB - ALBEMARLE CORP | 5,142,733,000 | 2025 | -9.93% | -7.14% | -4.37% | -5.76 |
| AXTA - Axalta Coating Systems Ltd. | 5,117,000,000 | 2025 | 7.39% | 14.36% | -3.01% | 1.74 |
| ELAN - Elanco Animal Health Inc | 4,715,000,000 | 2025 | -4.92% | | 6.22% | -0.47 |
| IDXX - IDEXX LABORATORIES INC /DE | 4,303,702,000 | 2025 | 24.62% | 31.60% | 10.42% | 13.08 |
| JAZZ - Jazz Pharmaceuticals plc | 4,267,586,000 | 2025 | -8.35% | -10.08% | 4.88% | -5.84 |
| PRGO - PERRIGO Co plc | 4,253,100,000 | 2025 | -33.51% | -26.39% | -2.75% | -10.29 |
| SOLS - Solstice Advanced Materials Inc. | 3,886,000,000 | 2025 | 6.10% | | 3.08% | 1.49 |
| ALNY - ALNYLAM PHARMACEUTICALS, INC. | 3,713,937,000 | 2025 | 8.45% | 13.51% | 65.19% | 2.33 |
| CBT - CABOT CORP | 3,713,000,000 | 2025 | 8.91% | 16.73% | -7.04% | 6.02 |
| FUL - FULLER H B CO | 3,473,589,000 | 2025 | 4.37% | 9.76% | -2.67% | 2.75 |
| FMC - FMC CORP | 3,467,400,000 | 2025 | -64.57% | -46.96% | -18.34% | -17.88 |
| SMG - SCOTTS MIRACLE-GRO CO | 3,413,100,000 | 2025 | 4.25% | 10.51% | -3.93% | 2.47 |
| AVNT - AVIENT CORP | 3,260,200,000 | 2025 | 2.51% | 6.24% | 0.61% | 0.89 |
| BMRN - BIOMARIN PHARMACEUTICAL INC | 3,221,253,000 | 2025 | 10.83% | 12.71% | 12.87% | 1.80 |
| UTHR - UNITED THERAPEUTICS Corp | 3,182,700,000 | 2025 | 41.94% | 46.89% | 10.61% | 27.86 |
| AMRX - Amneal Pharmaceuticals, Inc. | 3,018,760,000 | 2025 | 2.39% | 13.05% | 8.05% | 0.22 |
| TSEOQ - Trinseo PLC | 2,974,900,000 | 2025 | -18.34% | -8.54% | -15.32% | -15.24 |
| TROX - Tronox Holdings plc | 2,898,000,000 | 2025 | -16.22% | -8.73% | -5.73% | -2.97 |
| NBIX - NEUROCRINE BIOSCIENCES INC | 2,860,500,000 | 2025 | 16.73% | 21.64% | 21.45% | 4.67 |
| QDEL - QuidelOrtho Corp | 2,730,200,000 | 2025 | -41.45% | -33.67% | -1.89% | -16.69 |
| NEU - NEWMARKET CORP | 2,725,169,000 | 2025 | 15.37% | 19.95% | -2.20% | 44.44 |
| ESI - Element Solutions Inc | 2,551,200,000 | 2025 | 7.48% | 13.41% | 3.84% | 0.79 |
| RPRX - Royalty Pharma plc | 2,378,193,000 | 2025 | 32.42% | 65.58% | 5.06% | 1.78 |
| SCL - STEPAN CO | 2,332,114,000 | 2025 | 2.01% | 3.37% | 6.96% | 2.05 |
| EXEL - EXELIXIS, INC. | 2,320,126,000 | 2026 | 33.73% | 37.59% | 6.98% | 2.78 |
| EPC - EDGEWELL PERSONAL CARE Co | 2,223,500,000 | 2025 | 1.14% | 4.34% | -1.34% | 0.53 |
| SRPT - Sarepta Therapeutics, Inc. | 2,198,237,000 | 2025 | -32.45% | -31.83% | 15.58% | -7.13 |
| GPRE - Green Plains Inc. | 2,091,680,000 | 2025 | -5.80% | -3.22% | -14.93% | -1.80 |
| VHI - VALHI INC /DE/ | 2,077,000,000 | 2025 | -2.77% | 3.05% | -1.32% | -2.02 |
| MTX - MINERALS TECHNOLOGIES INC | 2,072,600,000 | 2025 | -0.89% | 2.29% | -2.17% | -0.59 |
| MRNA - Moderna, Inc. | 1,944,000,000 | 2025 | -145.16% | -121.91% | -39.93% | -7.26 |
| HXL - HEXCEL CORP /DE/ | 1,893,900,000 | 2025 | 5.78% | 9.06% | -0.48% | |
| KRO - KRONOS WORLDWIDE INC | 1,859,400,000 | 2025 | -5.96% | -1.96% | -1.47% | -0.96 |
| OEC - Orion S.A. | 1,806,700,000 | 2025 | -3.88% | 1.52% | -3.77% | -1.24 |
| IOSP - INNOSPEC INC. | 1,778,000,000 | 2025 | 6.56% | 7.28% | -3.65% | 4.67 |
| PTCT - PTC THERAPEUTICS, INC. | 1,730,655,000 | 2025 | 39.44% | 50.09% | 114.51% | 7.78 |
| ELF - e.l.f. Beauty, Inc. | 1,636,472,000 | 2026 | 1.61% | 4.50% | 24.59% | 0.44 |
| SXT - SENSIENT TECHNOLOGIES CORP | 1,612,111,000 | 2025 | 8.34% | 12.85% | 3.52% | 3.16 |
| LNTH - Lantheus Holdings, Inc. | 1,541,609,000 | 2025 | 15.15% | 20.16% | 0.50% | 3.41 |
| ASIX - AdvanSix Inc. | 1,522,233,000 | 2025 | 3.24% | | 0.31% | 1.80 |
| IPAR - INTERPARFUMS INC | 1,488,509,000 | 2025 | 11.31% | 18.16% | 2.49% | 5.24 |
| ALKS - Alkermes plc. | 1,475,899,000 | 2025 | 16.37% | 17.21% | -5.25% | 1.43 |
| HALO - HALOZYME THERAPEUTICS, INC. | 1,396,611,000 | 2025 | 22.69% | 33.58% | 37.55% | 2.56 |
| PAHC - PHIBRO ANIMAL HEALTH CORP | 1,296,215,000 | 2025 | 3.72% | 8.52% | 27.37% | 1.19 |
| INDV - Indivior Pharmaceuticals, Inc. | 1,239,000,000 | 2025 | 16.95% | 21.15% | 4.29% | 1.64 |
| TECH - BIO-TECHNE Corp | 1,219,635,000 | 2025 | 6.02% | 8.38% | 5.23% | 0.46 |
| NGVT - Ingevity Corp | 1,167,600,000 | 2025 | -14.31% | 35.86% | -2.71% | -4.61 |
| NVAX - NOVAVAX INC | 1,123,479,000 | 2025 | 39.19% | 40.30% | 64.69% | 2.58 |
| PBH - Prestige Consumer Healthcare Inc. | 1,088,705,000 | 2026 | 17.48% | 28.42% | -4.31% | 3.91 |
| CSW - CSW INDUSTRIALS, INC. | 1,082,549,000 | 2026 | 10.35% | 15.57% | 23.25% | 6.70 |
| ACAD - ACADIA PHARMACEUTICALS INC | 1,071,505,000 | 2025 | 36.49% | 9.78% | 11.87% | 2.30 |
| BCPC - BALCHEM CORP | 1,037,161,000 | 2025 | 14.93% | 20.18% | 8.75% | 4.75 |
| MDGL - MADRIGAL PHARMACEUTICALS, INC. | 958,403,000 | 2025 | -30.08% | -31.31% | 432.05% | -12.85 |
| IONS - IONIS PHARMACEUTICALS INC | 943,711,000 | 2025 | -40.41% | -40.45% | 33.83% | -2.38 |
| USNA - USANA HEALTH SCIENCES INC | 925,257,000 | 2026 | 1.16% | 4.05% | | 0.58 |
| NEOG - NEOGEN CORP | 894,661,000 | 2025 | -122.06% | -118.59% | -3.20% | -5.03 |
| ANIP - ANI PHARMACEUTICALS INC | 883,366,000 | 2025 | 8.87% | 12.58% | 43.78% | 3.32 |
| BCRX - BIOCRYST PHARMACEUTICALS INC | 874,837,000 | 2025 | 30.16% | 38.98% | 94.10% | 1.21 |
| HRMY - Harmony Biosciences Holdings, Inc. | 868,453,000 | 2025 | 18.27% | 24.00% | 21.51% | 2.71 |
| ARWR - ARROWHEAD PHARMACEUTICALS, INC. | 829,448,000 | 2025 | -0.20% | 11.86% | 23258.15% | -0.01 |
| MYGN - MYRIAD GENETICS INC | 824,500,000 | 2025 | -44.38% | -46.96% | -1.56% | -3.95 |
| ROG - ROGERS CORP | 810,800,000 | 2025 | -7.62% | -5.55% | -2.33% | -3.40 |
| COLL - COLLEGIUM PHARMACEUTICAL, INC | 780,567,000 | 2025 | 8.05% | 23.01% | 23.62% | 1.73 |
| CORT - CORCEPT THERAPEUTICS INC | 761,407,000 | 2025 | 13.09% | 5.88% | 12.79% | 0.82 |
| EBS - Emergent BioSolutions Inc. | 742,900,000 | 2025 | 7.08% | 13.47% | -28.81% | 0.93 |
| RGEN - REPLIGEN CORP | 738,256,000 | 2025 | 6.62% | 7.47% | 16.36% | 0.86 |
| PCRX - Pacira BioSciences, Inc. | 726,411,000 | 2025 | 0.97% | 2.64% | 3.63% | 0.16 |
| ECVT - Ecovyst Inc. | 723,515,000 | 2025 | -9.83% | 8.97% | 20.93% | -0.61 |
| AMPH - Amphastar Pharmaceuticals, Inc. | 719,887,000 | 2025 | 13.63% | 19.50% | -1.65% | 2.03 |
| SUPN - SUPERNUS PHARMACEUTICALS, INC. | 718,952,000 | 2025 | -5.36% | -8.66% | 8.63% | -0.68 |
| RARE - Ultragenyx Pharmaceutical Inc. | 673,000,000 | 2025 | -85.44% | -79.49% | 20.18% | -5.83 |
| PRM - Perimeter Solutions, Inc. | 652,862,000 | 2025 | -31.61% | -30.78% | 16.38% | -1.37 |
| REX - REX AMERICAN RESOURCES Corp | 650,487,000 | 2026 | 14.62% | | 1.24% | 2.50 |
| AXSM - Axsome Therapeutics, Inc. | 638,496,000 | 2025 | -28.69% | -26.12% | 65.55% | -3.68 |
| WDFC - WD 40 CO | 619,985,000 | 2025 | 14.68% | 16.74% | 4.98% | 6.69 |
| TGTX - TG THERAPEUTICS, INC. | 616,287,000 | 2025 | 72.56% | 20.01% | 87.32% | 2.77 |
| LXU - LSB INDUSTRIES, INC. | 615,208,000 | 2025 | 4.00% | 9.31% | 17.77% | 0.34 |
| OPK - OPKO HEALTH, INC. | 606,879,000 | 2025 | -37.19% | -19.35% | -14.90% | -0.30 |
| INSM - INSMED Inc | 606,423,000 | 2025 | | | 66.73% | -6.42 |
| CPRX - CATALYST PHARMACEUTICALS, INC. | 588,989,000 | 2025 | 36.39% | 43.77% | 19.78% | 1.68 |
| ORGO - Organogenesis Holdings Inc. | 564,169,000 | 2025 | 6.56% | 7.92% | 17.04% | 0.15 |
| MIRM - Mirum Pharmaceuticals, Inc. | 521,312,000 | 2025 | -4.48% | -4.25% | 54.74% | -0.47 |
| AVD - AMERICAN VANGUARD CORP | 515,114,000 | 2025 | -9.68% | -5.49% | -5.88% | -1.75 |
| ADMA - ADMA BIOLOGICS, INC. | 510,173,000 | 2025 | 28.80% | 37.53% | 19.63% | 0.60 |
| BBIO - BridgeBio Pharma, Inc. | 502,076,000 | 2025 | -145.98% | -104.25% | 126.26% | -3.78 |
| TVTX - Travere Therapeutics, Inc. | 490,728,000 | 2025 | -5.21% | -12.80% | 110.45% | -0.29 |
| NATR - NATURES SUNSHINE PRODUCTS INC | 480,144,000 | 2025 | 4.07% | 5.15% | 5.67% | 1.06 |
| TARS - Tarsus Pharmaceuticals, Inc. | 451,360,000 | 2025 | -14.72% | -15.72% | 146.71% | -1.59 |
| OLPX - OLAPLEX HOLDINGS, INC. | 422,960,000 | 2025 | -2.19% | 1.64% | 0.07% | -0.01 |
| INVA - Innoviva, Inc. | 411,328,000 | 2025 | 65.92% | 39.81% | 14.67% | 3.30 |
| ARDX - ARDELYX, INC. | 407,320,000 | 2025 | -15.12% | -10.06% | 22.09% | -0.26 |
| ESPR - Esperion Therapeutics, Inc. | 403,135,000 | 2025 | -5.63% | 14.95% | 21.31% | -0.11 |
| KRYS - Krystal Biotech, Inc. | 389,130,000 | 2025 | 52.64% | 41.45% | 33.94% | 6.84 |
| LXFR - LUXFER HOLDINGS PLC | 384,600,000 | 2025 | 2.00% | 6.24% | -1.86% | 0.28 |
| TWST - Twist Bioscience Corp | 376,572,000 | 2025 | -20.63% | -36.18% | 20.32% | -1.30 |
| ARQT - Arcutis Biotherapeutics, Inc. | 376,072,000 | 2025 | -4.29% | -3.25% | 91.34% | -0.13 |
| MNKD - MANNKIND CORP | 348,966,000 | 2025 | 1.68% | 11.12% | 22.23% | 0.02 |
| CRMD - CorMedix Inc. | 311,709,000 | 2025 | 52.31% | 48.17% | 617.03% | 2.04 |
| EOLS - Evolus, Inc. | 297,176,000 | 2025 | -17.38% | -10.99% | 11.61% | -0.80 |
| IRWD - IRONWOOD PHARMACEUTICALS INC | 296,151,000 | 2025 | 8.11% | 33.26% | -15.72% | 0.15 |
| XERS - Xeris Biopharma Holdings, Inc. | 291,845,000 | 2025 | 0.19% | 8.53% | 43.72% | 0.00 |
| ADPT - Adaptive Biotechnologies Corp | 276,976,000 | 2025 | -21.48% | -20.62% | 54.77% | -0.39 |
| VCEL - Vericel Corp | 276,259,000 | 2025 | 5.98% | 4.00% | 16.45% | 0.32 |
| HROW - HARROW, INC. | 272,303,000 | 2025 | -1.89% | 11.21% | 36.41% | -0.14 |
| LGND - LIGAND PHARMACEUTICALS INC | 268,087,000 | 2025 | 46.42% | 15.29% | 60.40% | 6.13 |
| IOVA - IOVANCE BIOTHERAPEUTICS, INC. | 263,502,000 | 2025 | -148.38% | | 60.60% | -1.09 |
| ARVN - ARVINAS, INC. | 262,600,000 | 2025 | -30.77% | -45.13% | -0.30% | -1.14 |
| SDGR - Schrodinger, Inc. | 255,869,000 | 2025 | -40.36% | -65.23% | 23.29% | -1.41 |
| RCUS - Arcus Biosciences, Inc. | 247,000,000 | 2025 | -142.91% | -127.91% | -4.26% | -3.29 |
| KROS - Keros Therapeutics, Inc. | 243,864,000 | 2025 | 35.68% | 27.71% | | 2.30 |
| FTK - FLOTEK INDUSTRIES INC/CN/ | 237,262,000 | 2025 | 12.87% | 9.80% | 26.86% | 0.84 |
| AKBA - Akebia Therapeutics, Inc. | 236,196,000 | 2025 | -2.26% | 9.95% | 47.46% | -0.02 |
| ANAB - ANAPTYSBIO, INC | 234,603,000 | 2025 | -5.64% | 20.42% | 157.01% | -0.46 |
| LFVN - Lifevantage Corp | 228,530,000 | 2025 | 4.29% | 5.34% | 14.17% | 0.75 |
| PBYI - PUMA BIOTECHNOLOGY, INC. | 228,371,000 | 2025 | 13.62% | 16.33% | -0.91% | 0.61 |
| IDYA - IDEAYA Biosciences, Inc. | 218,710,000 | 2025 | -51.99% | -72.84% | 3024.43% | -1.28 |
| VNDA - Vanda Pharmaceuticals Inc. | 216,105,000 | 2025 | -102.02% | -69.95% | 8.72% | -3.74 |
| BTMD - biote Corp. | 192,219,000 | 2025 | 14.07% | 18.50% | -2.52% | 0.74 |
| RYTM - RHYTHM PHARMACEUTICALS, INC. | 189,757,000 | 2025 | -103.57% | -101.19% | 45.83% | -3.11 |
| MRVI - MARAVAI LIFESCIENCES HOLDINGS, INC. | 185,743,000 | 2025 | -70.41% | -115.89% | -28.34% | -0.90 |
| STOK - Stoke Therapeutics, Inc. | 184,420,000 | 2025 | -3.73% | -11.16% | 404.50% | -0.12 |
| CYRX - Cryoport, Inc. | 176,177,000 | 2025 | 44.44% | -20.89% | 12.38% | 1.40 |
| PHAT - Phathom Pharmaceuticals, Inc. | 175,110,000 | 2025 | -126.35% | -91.36% | 216.93% | -3.03 |
| SNDX - Syndax Pharmaceuticals Inc | 172,352,000 | 2025 | 17.84% | 18.77% | 627.84% | -3.29 |
| RGNX - REGENXBIO Inc. | 170,441,000 | 2025 | -113.75% | -94.58% | 104.54% | -3.76 |
| DNA - Ginkgo Bioworks Holdings, Inc. | 170,155,000 | 2025 | | -132.14% | -25.06% | -5.64 |
| GEVO - Gevo, Inc. | 160,580,000 | 2025 | -21.07% | -12.59% | 849.33% | -0.14 |
| LQDA - Liquidia Corp | 158,320,000 | 2025 | -43.53% | -32.45% | 1031.18% | -0.80 |
| NL - NL INDUSTRIES INC | 158,285,000 | 2025 | -23.90% | 6.74% | 8.46% | -0.77 |
| HRTX - HERON THERAPEUTICS, INC. /DE/ | 154,904,000 | 2025 | -13.04% | -1.64% | 7.36% | -0.12 |
| BEAM - Beam Therapeutics Inc. | 139,743,000 | 2025 | -57.24% | -46.73% | 120.01% | -0.81 |
| NAGE - Niagen Bioscience, Inc. | 129,423,000 | 2025 | 13.43% | 12.58% | 29.95% | 0.20 |
| LFCR - LIFECORE BIOMEDICAL, INC. \DE\ | 128,867,000 | 2025 | -30.04% | -13.38% | 0.47% | -1.27 |
| XNCR - Xencor Inc | 125,576,000 | 2025 | -73.20% | -141.35% | 13.65% | -1.24 |
| GLUE - Monte Rosa Therapeutics, Inc. | 123,672,000 | 2025 | -31.23% | -43.83% | 63.54% | |
| ARQ - Arq, Inc. | 120,336,000 | 2025 | -43.72% | -44.01% | 10.44% | -1.27 |
| GYRE - GYRE THERAPEUTICS, INC. | 116,588,000 | 2025 | 8.47% | 9.85% | 10.24% | 0.02 |
| IBRX - ImmunityBio, Inc. | 113,288,000 | 2025 | | | 668.31% | -0.38 |
| URGN - UroGen Pharma Ltd. | 109,788,000 | 2025 | -139.81% | -113.73% | 21.45% | |
| TBPH - Theravance Biopharma, Inc. | 107,464,000 | 2025 | 98.54% | -3.35% | 66.92% | 2.06 |
| ZVRA - ZEVRA THERAPEUTICS, INC. | 106,470,000 | 2025 | 78.17% | -59.12% | 350.91% | 1.35 |
| ZYME - Zymeworks Inc. | 105,965,000 | 2025 | -76.56% | -87.34% | 38.87% | -1.08 |
| FF - FutureFuel Corp. | 95,742,000 | 2025 | -51.59% | -55.35% | -60.65% | -1.13 |
| SIGA - SIGA TECHNOLOGIES INC | 94,574,902 | 2025 | 24.61% | 25.06% | -31.82% | 0.32 |
| CYTK - CYTOKINETICS INC | 88,039,000 | 2025 | | | 376.56% | -6.54 |
| FDMT - 4D Molecular Therapeutics, Inc. | 85,209,000 | 2025 | | | 230194.59% | -2.42 |
| SPRY - ARS Pharmaceuticals, Inc. | 84,278,000 | 2025 | 8.97% | -3.46% | -5.46% | -1.74 |
| NRIX - Nurix Therapeutics, Inc. | 83,980,000 | 2025 | | | 53.95% | -3.05 |
| ARCT - Arcturus Therapeutics Holdings Inc. | 82,031,000 | 2025 | -80.19% | -92.96% | -46.14% | -2.40 |
| FTLF - FITLIFE BRANDS, INC. | 81,458,000 | 2025 | 7.77% | 12.35% | 26.35% | 0.63 |
| MGTX - MeiraGTx Holdings plc | 81,391,000 | 2025 | -140.31% | -130.20% | 144.57% | -1.42 |
| ADCT - ADC Therapeutics SA | 81,357,000 | 2025 | -74.86% | -149.34% | 14.85% | -1.12 |
| ETON - Eton Pharmaceuticals, Inc. | 79,950,000 | 2025 | -5.75% | -1.06% | 104.94% | |
| ACNT - ASCENT INDUSTRIES CO. | 74,942,000 | 2025 | 1.16% | -9.38% | -7.21% | 0.09 |
| RXRX - RECURSION PHARMACEUTICALS, INC. | 74,681,000 | 2025 | | | 26.92% | -1.44 |
| VRDN - Viridian Therapeutics, Inc.\DE | 70,849,000 | 2025 | | | 23359.93% | |
| CDXS - CODEXIS, INC. | 70,387,000 | 2025 | -62.47% | -59.30% | 18.61% | -0.50 |
| VIR - Vir Biotechnology, Inc. | 68,556,000 | 2025 | 31.92% | 51.56% | -7.61% | -3.16 |
| NTLA - Intellia Therapeutics, Inc. | 67,671,000 | 2025 | | | 16.92% | -3.81 |
| KURA - Kura Oncology, Inc. | 67,482,000 | 2025 | | | 25.24% | -3.18 |
| ENTA - ENANTA PHARMACEUTICALS INC | 65,324,000 | 2025 | -125.36% | -130.65% | -3.42% | -3.84 |
| NUVB - Nuvation Bio Inc. | 62,902,000 | 2025 | | | 698.96% | -0.60 |
| TNGX - Tango Therapeutics, Inc. | 62,384,000 | 2025 | | | 48.29% | -0.87 |
| SLSN - SOLESENCE, INC. | 62,064,000 | 2025 | 2.88% | 2.53% | 18.56% | 0.02 |
| DERM - Journey Medical Corp | 61,858,000 | 2025 | -18.48% | -13.21% | 10.20% | -0.47 |
| AGIO - AGIOS PHARMACEUTICALS, INC. | 54,028,000 | 2025 | | | | -7.12 |
| XOMA - XOMA Royalty Corp | 52,149,000 | 2025 | 60.81% | 21.83% | 83.06% | 1.46 |
| OCUL - OCULAR THERAPEUTIX, INC | 51,951,000 | 2025 | -138.14% | -140.96% | -18.47% | -1.42 |
| GOSS - Gossamer Bio, Inc. | 48,471,000 | 2025 | -49.28% | -52.24% | -57.74% | -0.75 |
| PTGX - Protagonist Therapeutics, Inc | 46,016,000 | 2025 | 63.34% | 58.20% | -89.41% | -2.05 |
| SEPN - Septerna, Inc. | 45,951,000 | 2025 | -106.37% | -148.63% | 4174.51% | -1.10 |
| FENC - FENNEC PHARMACEUTICALS INC. | 44,642,000 | 2025 | -21.82% | -14.07% | -6.09% | -0.34 |
| AQST - Aquestive Therapeutics, Inc. | 44,545,000 | 2025 | -76.68% | -53.46% | -22.61% | -0.78 |
| WVE - Wave Life Sciences Ltd. | 42,727,000 | 2025 | -89.57% | -101.94% | -60.55% | -1.21 |
| EDIT - Editas Medicine, Inc. | 40,520,000 | 2025 | -127.82% | -148.61% | 25.39% | -1.80 |
| TKNO - Alpha Teknova, Inc. | 40,520,000 | 2025 | -42.59% | -41.90% | 7.35% | -0.32 |
| VYGR - Voyager Therapeutics, Inc. | 40,374,000 | 2025 | -81.25% | -104.11% | -49.53% | -2.04 |
| KYMR - Kymera Therapeutics, Inc. | 39,211,000 | 2025 | -137.60% | -138.03% | -16.70% | -3.69 |
| VSTM - Verastem, Inc. | 30,914,000 | 2025 | | | 209.14% | -3.02 |
| FHTX - Foghorn Therapeutics Inc. | 30,909,000 | 2025 | | | 36.75% | -1.18 |
| TRDA - Entrada Therapeutics, Inc. | 25,421,000 | 2025 | 31.13% | 22.30% | -87.94% | -3.47 |
| ALMS - ALUMIS INC. | 24,050,000 | 2025 | | | | -2.86 |
| ASPI - ASP Isotopes Inc. | 23,849,000 | 2025 | | | 475.51% | -2.11 |
| ALEC - Alector, Inc. | 21,045,000 | 2025 | -118.39% | -144.19% | -79.07% | -1.39 |
| LENZ - LENZ Therapeutics, Inc. | 19,088,000 | 2025 | | | | -2.85 |
| RLAY - Relay Therapeutics, Inc. | 15,355,000 | 2025 | -63.41% | -67.51% | 53.44% | -1.61 |
| ABUS - Arbutus Biopharma Corp | 14,083,000 | 2025 | | | 128.21% | -0.17 |
| TNXP - Tonix Pharmaceuticals Holding Corp. | 13,107,000 | 2025 | | | 29.85% | -14.57 |
| EVMN - Evommune, Inc. | 13,000,000 | 2025 | | | 85.71% | -11.22 |
| JANX - Janux Therapeutics, Inc. | 10,000,000 | 2025 | | | -5.55% | -1.83 |
| ZBIO - Zenas BioPharma, Inc. | 10,000,000 | 2025 | -74.25% | -74.29% | 100.00% | -8.44 |
| TSHA - Taysha Gene Therapies, Inc. | 9,773,000 | 2025 | | | 17.28% | -0.34 |
| PGEN - PRECIGEN, INC. | 9,684,000 | 2025 | -53.32% | -62.83% | 146.73% | -1.37 |
| PRTA - PROTHENA CORP PUBLIC LTD CO | 9,684,000 | 2025 | -90.49% | -114.36% | -92.83% | -4.53 |
| BIOA - BioAge Labs, Inc. | 8,995,000 | 2025 | | | | -2.24 |
| PCT - PureCycle Technologies, Inc. | 8,355,000 | 2025 | | | | -1.21 |
| ROIV - Roivant Sciences Ltd. | 8,260,000 | 2026 | | | -71.57% | -0.54 |
| ACRS - Aclaris Therapeutics, Inc. | 7,826,000 | 2025 | | | -58.19% | -0.53 |
| CRNX - Crinetics Pharmaceuticals, Inc. | 7,696,000 | 2025 | | | 640.71% | -4.95 |
| XENE - Xenon Pharmaceuticals Inc. | 7,500,000 | 2025 | -89.65% | -97.31% | | -4.36 |
| IMNM - Immunome Inc. | 6,941,000 | 2025 | | | -23.23% | -2.43 |
| FATE - FATE THERAPEUTICS INC | 6,646,000 | 2025 | | | -51.24% | -1.15 |
| KRRO - Korro Bio, Inc. | 6,392,000 | 2025 | | | 181.46% | -12.48 |
| PRME - Prime Medicine, Inc. | 4,632,000 | 2025 | -65.45% | -17.89% | 55.28% | -1.35 |
| CGON - CG Oncology, Inc. | 4,040,000 | 2025 | | | 254.70% | -2.08 |
| CRSP - CRISPR Therapeutics AG | 3,510,000 | 2025 | -41.38% | -59.95% | -90.59% | -6.47 |
| UPB - Upstream Bio, Inc. | 2,854,000 | 2025 | | | 20.42% | -2.66 |
| RNAC - Cartesian Therapeutics, Inc. | 2,797,000 | 2025 | | -112.81% | -92.81% | -5.02 |
| HUMA - Humacyte, Inc. | 2,038,000 | 2025 | | | | -0.26 |
| DNTH - Dianthus Therapeutics, Inc. /DE/ | 2,036,000 | 2025 | | | -67.35% | -4.20 |
| CLDX - Celldex Therapeutics, Inc. | 1,545,000 | 2025 | | | -77.99% | -3.90 |
| INBX - Inhibrx Biosciences, Inc. | 1,300,000 | 2025 | | | | -9.04 |
| CRDF - Cardiff Oncology, Inc. | 593,000 | 2025 | | | -13.18% | -0.69 |
| ATYR - aTYR PHARMA INC | 190,000 | 2025 | | | -19.15% | -0.80 |
| INMB - Inmune Bio, Inc. | 50,000 | 2025 | | | 257.14% | -1.86 |
| ALT - Altimmune, Inc. | 41,000 | 2025 | | | 105.00% | -1.00 |
| AARD - Aardvark Therapeutics, Inc. | | | | | | -2.93 |
| ABEO - ABEONA THERAPEUTICS INC. | | | | | | 1.01 |
| ACTU - ACTUATE THERAPEUTICS, INC. | | | | | | -1.06 |
| AKTS - Aktis Oncology, Inc. | | | | | | |
| ALDX - Aldeyra Therapeutics, Inc. | | | | | | -0.56 |
| ALLO - Allogene Therapeutics, Inc. | | | | | | -0.87 |
| AMLX - Amylyx Pharmaceuticals, Inc. | | | | | | -1.53 |
| ANNX - Annexon, Inc. | | | | | | -1.34 |
| APGE - Apogee Therapeutics, Inc. | | | | | | -4.22 |
| AUPH - Aurinia Pharmaceuticals Inc. | | | | | | 2.07 |
| AURA - Aura Biosciences, Inc. | | | | | | -1.76 |
| AVBP - ArriVent BioPharma, Inc. | | | | | | -4.32 |
| AVIR - Atea Pharmaceuticals, Inc. | | | | | | -1.94 |
| AVXL - ANAVEX LIFE SCIENCES CORP. | | | | | | -0.54 |
| BCAX - Bicara Therapeutics Inc. | | | | | | -2.52 |
| BHVN - Biohaven Ltd. | | | | | | -6.86 |
| BNTC - Benitec Biopharma Inc. | | | | | | -1.05 |
| CADL - Candel Therapeutics, Inc. | | | | | | -0.72 |
| CAPR - CAPRICOR THERAPEUTICS, INC. | | | | | | -2.26 |
| CATX - Perspective Therapeutics, Inc. | | | | | | -1.40 |
| CGEM - Cullinan Therapeutics, Inc. | | | | | | |
| CHRS - Coherus Oncology, Inc. | | | | | | 1.43 |
| CMPX - Compass Therapeutics, Inc. | | | | | | |
| COGT - Cogent Biosciences, Inc. | | | | | | -2.16 |
| CRVS - Corvus Pharmaceuticals, Inc. | | | | | | -0.53 |
| DFTX - Definium Therapeutics, Inc. | | | | | | -2.06 |
| DMAC - DiaMedica Therapeutics Inc. | | | | | | |
| DNLI - Denali Therapeutics Inc. | | | | | | -2.97 |
| DSGN - Design Therapeutics, Inc. | | | | | | -1.22 |
| DYN - Dyne Therapeutics, Inc. | | | | | | -3.47 |
| ELDN - Eledon Pharmaceuticals, Inc. | | | | | | -0.52 |
| ELVN - Enliven Therapeutics, Inc. | | | | | | -1.83 |
| ERAS - Erasca, Inc. | | | | | | -0.44 |
| EWTX - Edgewise Therapeutics, Inc. | | | | | | -1.63 |
| FULC - Fulcrum Therapeutics, Inc. | | | | | | -1.18 |
| GERN - GERON CORP | | | | | | -0.13 |
| GLSI - Greenwich LifeSciences, Inc. | | | | | | -1.43 |
| HURA - TuHURA Biosciences, Inc./NV | | | | | | -0.63 |
| IKT - Inhibikase Therapeutics, Inc. | | | | | | -0.49 |
| IMVT - Immunovant, Inc. | | | | | | -2.77 |
| IRON - Disc Medicine, Inc. | | | | | | -6.01 |
| JBIO - Jade Biosciences, Inc. | | | | | | -3.19 |
| KOD - Kodiak Sciences Inc. | | | | | | -4.32 |
| LBRX - LB PHARMACEUTICALS INC | | | | | | -3.13 |
| LRMR - Larimar Therapeutics, Inc. | | | | | | -1.32 |
| LTBR - LIGHTBRIDGE Corp | | | | | | -0.81 |
| LXEO - Lexeo Therapeutics, Inc. | | | | | | -1.86 |
| MAZE - Maze Therapeutics, Inc. | | | | | | -3.05 |
| MBX - MBX Biosciences, Inc. | | | | | | -2.38 |
| MLYS - Mineralys Therapeutics, Inc. | | | | | | -2.29 |
| MNPR - Monopar Therapeutics | | | | | | |
| MPLT - MapLight Therapeutics, Inc. | | | | | | -18.56 |
| NGNE - Neurogene Inc. | | | | | | -4.24 |
| NKTX - Nkarta, Inc. | | | | | | -1.41 |
| NUVL - Nuvalent, Inc. | | | | | | -5.85 |
| NVCT - Nuvectis Pharma, Inc. | | | | | | -1.32 |
| OLMA - Olema Pharmaceuticals, Inc. | | | | | | -1.87 |
| OMER - OMEROS CORP | | | | | | -0.05 |
| ORIC - Oric Pharmaceuticals, Inc. | | | | | | -1.47 |
| ORKA - Oruka Therapeutics, Inc. | | | | | | -3.87 |
| PCVX - Vaxcyte, Inc. | | | | | | -5.63 |
| PRAX - Praxis Precision Medicines, Inc. | | | | | | -13.48 |
| PVLA - PALVELLA THERAPEUTICS, INC. | | | | | | -3.71 |
| RAPP - Rapport Therapeutics, Inc. | | | | | | -2.86 |
| RCKT - ROCKET PHARMACEUTICALS, INC. | | | | | | -2.01 |
| REPL - Replimune Group, Inc. | | | | | | -3.07 |
| RIGL - RIGEL PHARMACEUTICALS INC | | | | | | 19.48 |
| RVMD - Revolution Medicines, Inc. | | | | | | -5.95 |
| RZLT - Rezolute, Inc. | | | | | | -0.98 |
| SAFX - XCF Global, Inc. | | | | | | 0.52 |
| SANA - Sana Biotechnology, Inc. | | | | | | -0.96 |
| SION - Sionna Therapeutics, Inc. | | | | | | -1.88 |
| SLDB - Solid Biosciences Inc. | | | | | | -1.99 |
| SLS - SELLAS Life Sciences Group, Inc. | | | | | | -0.25 |
| SMMT - Summit Therapeutics Inc. | | | | | | -1.44 |
| SRRK - Scholar Rock Holding Corp | | | | | | -3.29 |
| SVRA - Savara Inc | | | | | | -0.53 |
| SYRE - Spyre Therapeutics, Inc. | | | | | | |
| TARA - Protara Therapeutics, Inc. | | | | | | -1.34 |
| TECX - Tectonic Therapeutic, Inc. | | | | | | -4.05 |
| TRVI - Trevi Therapeutics, Inc. | | | | | | -0.32 |
| TVGN - Tevogen Bio Holdings Inc. | | | | | | -8.08 |
| TVRD - Tvardi Therapeutics, Inc. | | | | | | -3.26 |
| TYRA - Tyra Biosciences, Inc. | | | | | | -2.01 |
| VERA - Vera Therapeutics, Inc. | | | | | | -4.66 |
| VGAS - Verde Clean Fuels, Inc. | | | | | | -0.53 |
| VKTX - Viking Therapeutics, Inc. | | | | | | -3.19 |